Dr. Drake on Promise of Immunotherapy Combinations in Genitourinary Cancers

Charles G. Drake, MD, PhD
Published: Thursday, Feb 23, 2017



Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the potential of combinations between immunotherapy and conventional therapies in genitourinary cancers.

Combinations of chemotherapy and immunotherapy are showing promise in bladder cancer, where traditional chemotherapy regimens are given upfront with immunotherapy. Drake predicts higher response rates and increased progression-free survival, but questions on overall survival remain.

Another combination that is potentially exciting, says Drake, is pairing hormonal therapy with immunotherapy in prostate cancer. Trials were conducted in patients before surgery, where immunotherapy seemed to be an effective addition to hormonal therapy.
 


Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the potential of combinations between immunotherapy and conventional therapies in genitourinary cancers.

Combinations of chemotherapy and immunotherapy are showing promise in bladder cancer, where traditional chemotherapy regimens are given upfront with immunotherapy. Drake predicts higher response rates and increased progression-free survival, but questions on overall survival remain.

Another combination that is potentially exciting, says Drake, is pairing hormonal therapy with immunotherapy in prostate cancer. Trials were conducted in patients before surgery, where immunotherapy seemed to be an effective addition to hormonal therapy.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Renal Cell Carcinoma in an Era of Rapid Discovery: Key QuestionsJan 30, 20181.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x